[The transdermal 7-day buprenorphine patch--an effective and safe treatment option, if tramadol or tilidate/naloxone is insufficient. Results of a non-interventional study].
Schutter
Ulf
U
Allgemeinmedizin, Anästhesiologie, Spezielle Schmerztherapie, Palliativmedizin, Notfallmedizin, Facharztzentrum am Marienhospital, Marl. ulf.schutter@web.de
Ritzdorf
I
I
Heckes
B
B
D000279:Administration, Cutaneous; D000701:Analgesics, Opioid / Q000008:administration & dosage*; D002047:Buprenorphine / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D009068:Movement; D009270:Naloxone / Q000008:administration & dosage*; D010147:Pain Measurement; D010349:Patient Compliance; D011292:Premedication; D011788:Quality of Life; D013993:Tilidine / Q000008:administration & dosage*; D013997:Time Factors; D014147:Tramadol / Q000008:administration & dosage*; D016896:Treatment Outcome
D000701:Analgesics, Opioid; D009270:Naloxone; D014147:Tramadol; D002047:Buprenorphine; D013993:Tilidine